Overview Financials News + Filings Key Docs Charts Ownership Insiders
All All (ex-4s) 10-K 10-Q 8-K 3,4,5 Proxy Prospectus Other
Tags Quarterly results Director departure Credit agrmnt [a] Appointed director
|
Inotiv, Inc. (BASI)
|
Create: Alert |
All | News | Filings
Date Filed | Type | Description |
03/19/2021 |
GN
| Bioanalytical Systems, Inc. Announces Corporate Name Change to Inotiv, Inc. |
03/17/2021 |
GN
| Bioanalytical Systems, Inc., doing business as Inotiv, Announces Plan to Expand Service Offerings to Include Cardiovascular Safety Pharmacology |
03/09/2021 |
GN
| Bioanalytical Systems, Inc., doing business as Inotiv, Invests in Additional Vivarium Capacity at Facility in West Lafayette, IN |
03/04/2021 |
GN
| Bioanalytical Systems, Inc., doing business as Inotiv, to Participate in the H.C. Wainwright Global Life Sciences Virtual Conference |
02/24/2021 |
GN
| Bioanalytical Systems, Inc., doing business as Inotiv, Invests in Laboratory Infrastructure and Data and Study Management Technologies |
01/26/2021 |
GN
| Bioanalytical Systems, Inc., to Report First Quarter Fiscal 2021 Financial Results and Host Conference Call on Tuesday, February 9, 2021 |
01/19/2021 |
GN
| Inotiv Broadens Pathology Service Offerings |
01/11/2021 |
GN
| Daniel Smeak, DVM, ACVS, Joins Inotiv as Vice President, Surgical Models |
12/21/2020 |
GN
| BASi Releases Earnings for Fourth Quarter of Fiscal 2020 |
10/20/2020 |
GN
| Andrew N. Alexander, DVM, Ph.D., MBA, DABT, Joins Inotiv as Vice President, Pharmacology and Toxicology Operations |
08/14/2020 |
GN
| BASi Releases Earnings for Third Quarter of Fiscal 2020 |
08/11/2020 |
GN
| I.M. (Gina) Grossi, Ph.D., Joins Inotiv as Vice President of Toxicology to Drive Growth of Expanding Toxicology Business |
05/14/2020 |
GN
| BASi Releases Earnings for Second Quarter of Fiscal 2020 |
05/05/2020 |
GN
| Diane Tutko Francisco, Ph.D., Joins Inotiv to Lead Client Experience Team |
03/11/2020 |
GN
| Bioanalytical Systems, Inc., Announces Change of Time and Location of the Annual Meeting of Shareholders |
03/09/2020 |
GN
| Bioanalytical Systems, Inc. d/b/a Inotiv Appoints Beth A. Taylor as New Chief Financial Officer |
02/14/2020 |
GN
| BASi Releases Earnings for First Quarter of Fiscal 2020 |
12/23/2019 |
GN
| BASi Closes Fiscal 2019 with Strong Fourth Quarter |
12/03/2019 |
GN
| Inotiv, a BASi Company, Announces Closing of Pre-Clinical Research Services Transaction, Including New Financing to Fund the Transaction and Expand Discovery and DMPK Business |
11/14/2019 |
GN
| BASi Launches Rebrand of its Contract Research Services Business Under the Name Inotiv |
11/08/2019 |
GN
| BASi Announces Expansion into Surgical Models and Medical Devices with Agreement to Purchase Pre-Clinical Research Services |
10/01/2019 |
GN
| Stewart B. Jacobson, DVM, DACVP, Joins BASi as Vice President, Pathology, Filling Key Scientific Leadership Position |
08/14/2019 |
GN
| BASi Continues Revenue Growth in Third Quarter of Fiscal 2019 |
05/15/2019 |
GN
| BASi Continues Revenue Growth in Second Quarter of Fiscal 2019 |
05/10/2019 |
GN
| Bioanalytical Systems to Release Second Quarter Fiscal 2019 Results on Wednesday, May 15, 2019 |
05/07/2019 |
GN
| CORRECTED PRESS RELEASE: BASi Acquires the Smithers Avanza Toxicology Services Business Unit to Support Growing Toxicology Business and Broaden Scientific Talent |
05/01/2019 |
GN
| BASi Acquires the Smithers Avanza Toxicology Services Business Unit to Support Growing Toxicology Business and Broaden Scientific Talent |
03/07/2019 |
GN
| J. Scott Daniels, PhD, Joins BASi as Senior Vice President of DMPK, Filling Key Scientific Leadership Position |
02/21/2019 |
GN
| BASi Appoints Joe Flynn as Chief Commercial Officer |
02/15/2019 |
GN
| BASi Appoints Senior Contract Research Executive, D. Thomas Oakley, as Chief Operating Officer |
02/14/2019 |
GN
| BASi Reports Revenue Growth in First Quarter of Fiscal 2019 |
02/12/2019 |
GN
| Bioanalytical Systems to Release First Quarter Fiscal 2019 Results on Thursday, February 14, 2019 |
01/16/2019 |
GN
| BASi Elects Entrepreneur, Who Has Led BASi Turnaround and Recent Growth, as President and Chief Executive Officer and a Director |
12/20/2018 |
GN
| BASi Continues Revenue Gains to Close Fiscal 2018 |
|
|
|